Navigation Links
Medarex to Present at the 29th Annual Goldman Sachs Healthcare Conference
Date:6/3/2008

PRINCETON, N.J., June 3 /PRNewswire-FirstCall/ -- Medarex, Inc. (Nasdaq: MEDX) announced today that it is scheduled to present at the 29th Annual Goldman Sachs Healthcare Conference at 1:25 p.m. Eastern Time on Tuesday, June 10, 2008. The event will be webcast live and will be available in the Investor Relations section of the Medarex website at http://www.medarex.com. An archived edition of the presentation will be available following the event.

About Medarex

Medarex is a biopharmaceutical company focused on the discovery, development and potential commercialization of fully human antibody-based therapeutics to treat life-threatening and debilitating diseases, including cancer, inflammation, autoimmune disorders and infectious diseases. Medarex applies its UltiMAb(R) technology and product development and clinical manufacturing experience to generate, support and potentially commercialize a broad range of fully human antibody product candidates for itself and its partners. More than 40 of these therapeutic product candidates derived from Medarex technology are in human clinical testing or have had INDs submitted for such trials, with seven of the most advanced product candidates currently in Phase 3 clinical trials or the subject of regulatory applications for marketing authorization. Medarex is committed to building value by developing a diverse pipeline of antibody products to address the world's unmet healthcare needs. For more information about Medarex, visit its Web site at http://www.medarex.com.

Medarex(R), the Medarex logo and UltiMAb(R) are registered trademarks of Medarex, Inc. All rights are reserved. '/>"/>

SOURCE Medarex, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Medarex to Present at the Bank of America 2008 Healthcare Conference
2. Medarex to Present at the Morgan Stanley Global Healthcare Unplugged Conference
3. Medarex Reports Phase 1/2 Clinical Data of MDX-060 in Lymphoma at American Association for Cancer Research Meeting
4. Medarex to Receive Milestone Payment from Novo Nordisk
5. Medarex Receives Milestone Payment for Submission of Regulatory Application Requesting Approval of Golimumab (CNTO 148) in Europe for the Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis
6. Medarex Announces Presentations at Annual Meeting of the American Association for Cancer Research
7. Medarex to Present at the Susquehanna Financial Group Healthcare Conference
8. Medarex to Announce 2007 Fourth Quarter and Year-End Financial Results on Tuesday, February 26, 2008
9. Medarex Announces Completion of Sale of Shares in Genmab A/S
10. Medarex to Present at the 26th Annual JPMorgan Healthcare Conference
11. Medarex Announces Election of Marc Rubin as New Board Member
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2008)... Consumers cutting "experimental luxuries...ents seek out comparable alternatives at more affo...pamper them, they pamper themselves by re-creating...ome. ZhnSpa, a new spa facial line, meets this g...of the day spa. , West Pa...
(Date:12/2/2008)... Major biopharmaceutical companies with substa...re forecast to have adequate internal manufacturin...cturers (CMOs) however, are likely to feel the pre...Os and biopharmaceutical companies depending on th...factors and manufacturing trends is instrumental t...
(Date:12/1/2008)...are everywhere in our modern world, largely due to...rable, but lightweight and easily workable. One of...y to bend rather than break when put under stress ...y, described as "plastic flow", allows many plasti...eaking apart, says University of Wisconsin-Madison...
(Date:12/1/2008)...RNewswire-FirstCall/ -- Anadys Pharmaceuticals, In... Food and Drug Administration (FDA) has granted fa...f chronic hepatitis C virus (HCV) infection. ANA5...eoside polymerase inhibitor. Anadys is currently ...ANA598 for the treatment of patients chronically i...
Breaking Biology Technology:ZhenSpa.com provides Spa Enthusiasts Affordable Alternatives for Expensive Spa Treatments 2ZhenSpa.com provides Spa Enthusiasts Affordable Alternatives for Expensive Spa Treatments 3ZhenSpa.com provides Spa Enthusiasts Affordable Alternatives for Expensive Spa Treatments 4PharmSource and BioProcess Technology Consultants Announce Publication of New Market Report: Cell Culture Manufacturing Capacity: Trends and Outlook through 2013 2Fast molecular rearrangements hold key to plastic's toughness 2Fast molecular rearrangements hold key to plastic's toughness 3ANA598 Receives Fast Track Designation From the FDA for the Treatment of Chronic Hepatitis C Infection 2ANA598 Receives Fast Track Designation From the FDA for the Treatment of Chronic Hepatitis C Infection 3ANA598 Receives Fast Track Designation From the FDA for the Treatment of Chronic Hepatitis C Infection 4ANA598 Receives Fast Track Designation From the FDA for the Treatment of Chronic Hepatitis C Infection 5
...is . - A Green Bay soil-technology company that us...products to market has won the 2006 Governor,s Sma...00 prize that comes with it. , , ENCAP, LLC , whi...nology products, was presented the award during th...ymposium presented by the Wisconsin Technology C...
...is. - CDW Corp. , the Illinois-based technology ...n Networks , is elevating a top salesman to handle...pany has put vice president of sales Steven Schuld...hnology solutions provider, into CDW. , ,CDW, head...ately-held Berbee on Oct. 11 for approximately $18...
...is. - Mirus Bio Corp. , a Madison-based biotechn... outside the U.S., that covers a method of treatin...ith an injection of genes. , ,The patent, titled "...method for delivering a wide range of therapeutic ... and compliments a patent already obtained in the ...
...is. -You,re in an elevator next to a venture capi...but doesn,t know the first thing about it yet. , ...That,s the premise of the Elevator Pitch Olympics,...osium . This year, a panel of eight investors dish...repreneurs who presented their businesses in front...
Other Biology Technology:Green Bay's ENCAP wins tech transfer award 2Mirus granted European patent for gene therapy 29 tips for making 90 seconds count in an investment pitch 2
(Date:12/1/2008)...vailable at the online site of the journal Biolog...orts for the first time that vitamin D induces imm...production of the antimicrobial protein cathelicid... trophoblast cells to the active form of vitamin D...reased antibacterial response in the trophoblast c...
(Date:12/1/2008)... The Missouri Botanical Garden Press (MBG Press) ...the species of vascular plants for the Southern Co.... Catlogo de las Plantas Vasculares del Cono Sur (... taxonomic checklist of the plants of Argentina, s...database is essentially a dictionary to the names ...
(Date:12/1/2008)..., R.I. [Brown University] Gray mold is a gardener...ific name Botrytis cinerea , is a scourge to more...s, including staples such as tomatoes, strawberrie...e, peas, peppers, and potatoes. Gray mold envelops...hat poisons the host plants, cells, eventually cau...
(Date:12/1/2008).... In the race for bioengineered crops, sequencing... multi-leg relay. Once the sequence is complete, t...ify genes, functions. A draft sequence of the soyb...me will be available soon. Taking the next step in...nary Plant Group researchers have demonstrated the...
Breaking Biology News(10 mins):Missouri Botanical Garden publishes first catalogue of plants of the Southern Cone 2Brown chemist finds gray mold's killer gene 2Tool helps identify gene function in soybeans 2Warburg Pincus Acquires 5 4 25 of WuXi PharmaTechs Outstanding Ordinary Shares from United Overseas Bank 6535 1Warburg Pincus Acquires 5 4 25 of WuXi PharmaTechs Outstanding Ordinary Shares from United Overseas Bank 6535 2Warburg Pincus Acquires 5 4 25 of WuXi PharmaTechs Outstanding Ordinary Shares from United Overseas Bank 6535 3Nets Star Josh Boone Kicks Off Free Summer Meals Program 23965 1Warfarin Safer Than Heparin for Some Strokes 23963 1Warfarin Safer Than Heparin for Some Strokes 23963 2Closing coal burning power plant in China and improved cognitive development in children 23959 1Closing coal burning power plant in China and improved cognitive development in children 23959 2Closing coal burning power plant in China and improved cognitive development in children 23959 3
...ogists at the University at Buffalo have shown for...ing antifungal agent in saliva, kills the oral pat... most HIV-related oral infections. , Researchers ...at histatin binds to a specific membrane protein c...rough the cell membrane of the pathogenic fungus C...
...tients may one day benefit from treatment with mix...ed recently in the Proceedings of the National Aca...te scientists have demonstrated how the right comb...cell,s communication network, ultimately demobiliz...research led to the identification of a family of ...
...and Drug Administration (FDA) today announced a se...ing of the non-steroidal anti-inflammatory class o...n and non-prescription (over-the-counter (OTC)) no...ducts is available on the Internet at http://www.f...ay,s actions protect and advance the health of the...
... of a new technique to map connections among nerve...Center scientist dreaming of solving the mysteries... mouse brain stimulate others, researchers in Japa...on responsible for keeping animals awake receives ... sleep, as well as reinforcing, positive signals f...
Other Biology News:Discovery may lead to better Candidiasis drug 2Two are better than one 2FDA Announces Series of Changes to the Class of Marketed Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) 2Brain-mapping technique aids understanding of sleep, wakefulness 2Brain-mapping technique aids understanding of sleep, wakefulness 3
Anti-Kusabira Orange Monoclonal Antibody Description: 100 g Research Focus: tag Storage: -20C Shipping Temperature: 4C
PURA Immunogen: PURA (NP_005850, 183 a.a. ~ 293 a.a) partial recombinant protein with GST tag. Storage: -20 C, Avoid Freeze/Thaw Cycles *Available for distribution in the US only
Rabbit polyclonal to CAMK 1D beta ( Abpromise for all tested applications). entrezGeneID: 57118 SwissProtID: Q5SQQ7
Acetyl-Histone H2B (Lys20) Antibody
Biology Products: